In the field of gynecology, bisphosphonates are particularly significant for postmenopausal women. Estrogen deficiency post-menopause can lead to rapid bone loss, making women more susceptible to osteoporosis and fractures. Bisphosphonates help mitigate this risk by maintaining bone density.
